This United Therapeutics Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. Mizuho analyst Nick Setyan upgraded BJ’s Restaurants Inc (NASDAQ:BJRI) from Neutral to Outperform and raised the price target from $74 to $76. BJ’s Restaurants closed at $57.29 on Wednesday. See how other analysts view this stock. BTIG analyst Julian Harrison upgraded United Therapeutics Corporation (NASDAQ:UTHR) from Neutral to Buy and announced a $728 price target. United Therapeutics shares closed at $541.89 on Wednesday. See how other analysts view this stock. Goldman Sachs analyst Neil Mehta upgraded Occidental Petroleum Corporation (NYSE:OXY) from Neutral to Buy and boosted the price target from $63 to $69. Occidental Petroleum closed at $55.32 on Wednesday. See how other analysts view this stock. Wells Fargo analyst Sam Margolin upgraded BP p.l.c. (NYSE:BP) from Equal-Weight to Overweight and raised the price target from $48 to $57. BP shares closed at $43.99 on Wednesday. See how other analysts view this stock. Argus Research analyst Jasper Hellweg upgraded Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) from Hold to Buy and announced a price target of $850. Regeneron Pharmaceuticals closed at $758.27 on Wednesday. See how other analysts view this stock. Considering buying UTHR stock? Here’s what analysts think:Photo via Shutterstock